Mesoporous silica nanoparticle-based H2O2 responsive controlled-release system used for Alzheimer's disease treatment (Q39513747)

12 September 2017

title

Mesoporous silica nanoparticle-based H2O2 responsive controlled-release system used for Alzheimer's disease treatment (English)

1 reference

12 September 2017

0 references

0 references

Jie Geng

1

1 reference

12 September 2017

Meng Li

2

1 reference

12 September 2017

Li Wu

3

1 reference

12 September 2017

Cuie Chen

4

1 reference

12 September 2017

Xiaogang Qu

5

1 reference

12 September 2017

publication date

5 April 2012

1 reference

Advanced Healthcare Materials

12 September 2017

published in

1 reference

12 September 2017

volume

1

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

332-336

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

12 September 2017

1 reference

Copper, iron and zinc in Alzheimer's disease senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

The metallobiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Therapeutic approaches to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

The curious case of clioquinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Alzheimer's disease drug development and the problem of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

A prochelator activated by hydrogen peroxide prevents metal-induced amyloid Beta aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

A prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Small molecule modulators of copper-induced Abeta aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Targeted RNA interference of cyclin A2 mediated by functionalized single-walled carbon nanotubes induces proliferation arrest and apoptosis in chronic myelogenous leukemia K562 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Nanoparticle technology for drug delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Nanoparticle and other metal chelation therapeutics in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Mesoporous silica nanoparticles for intracellular controlled drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Stimuli-responsive controlled-release system using quadruplex DNA-capped silica nanocontainers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Photoresponsive cyclodextrin-covered nanocontainers and their sol-gel transition induced by molecular recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Controlled delivery systems using antibody-capped mesoporous nanocontainers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

pH- and photo-switched release of guest molecules from mesoporous silica supports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Design and optimization of molecular nanovalves based on redox-switchable bistable rotaxanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

A novel profluorescent probe for detecting oxidative stress induced by metal and H(2)O(2) in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

A selective, cell-permeable optical probe for hydrogen peroxide in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Highly specific enrichment of glycopeptides using boronic acid-functionalized mesoporous silica

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

A biocompatible oxidation-triggered carrier polymer with potential in therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Alzheimer's disease amyloid beta converting left-handed Z-DNA back to right-handed B-form

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Different hydration changes accompanying copper and zinc binding to amyloid beta-peptide: water contribution to metal binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Time-dependent DNA condensation induced by amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

A detailed examination of boronic acid–diol complexation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200067

21 January 2018

Identifiers

DOI

10.1002/ADHM.201200067

1 reference

release_eqojhuazwfff3hex3ibanqq6aq

12 September 2017

Fatcat ID

0 references

1 reference